Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
주식 순위 #20651
Nuformix plc operates in the field of pharmaceutical development for treating... Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
주가
$0.00244926
시가총액
$51.67K
변동 (1일)
5.88%
변동 (1년)
110.15%
국가
GB
거래 Nuformix plc (NFX)

카테고리

Nuformix plc (NFX)의 EPS
September 2025 기준 EPS TTM: $0.00
Nuformix plc의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $0.00입니다. 2024년 말에는 회사의 EPS가 $-0.01였으며, 이는 2023년의 EPS $0.00와 감소입니다.
Nuformix plc의 EPS 기록 (2014 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) 0.00 -100.00%
2025 0.00 -100.00%
2024 $-0.01 520.00%
2023 0.00 -60.00%
2022 0.00 -16.67%
2021 0.00 50.00%
2020 0.00 -57.45%
2019 0.00 -31.88%
2018 $-0.01 -23.33%
2017 $-0.01 8.43%
2016 $-0.01 0.00%
2014 0.00 0.00%
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
$3.62 -402,577.78%
DK
$15.47 -1,718,988.89%
US
$43.12 -4,791,211.11%
US
$9.62 -1,069,077.78%
BE
$2.98 -331,211.11%
AU